303 related articles for article (PubMed ID: 2375629)
1. Amyotrophic lateral sclerosis: amino acid levels in plasma and cerebrospinal fluid.
Perry TL; Krieger C; Hansen S; Eisen A
Ann Neurol; 1990 Jul; 28(1):12-7. PubMed ID: 2375629
[TBL] [Abstract][Full Text] [Related]
2. Abnormal glutamate metabolism in amyotrophic lateral sclerosis.
Plaitakis A; Caroscio JT
Ann Neurol; 1987 Nov; 22(5):575-9. PubMed ID: 2892463
[TBL] [Abstract][Full Text] [Related]
3. Free amino acid levels in amyotrophic lateral sclerosis.
Patten BM; Harati Y; Acosta L; Jung SS; Felmus MT
Ann Neurol; 1978 Apr; 3(4):305-9. PubMed ID: 666270
[TBL] [Abstract][Full Text] [Related]
4. [Free amino acid contents in the spinal cord of amyotrophic lateral sclerosis].
Fujita K; Nagata Y; Honda M
Rinsho Shinkeigaku; 1993 Sep; 33(9):985-7. PubMed ID: 7905368
[TBL] [Abstract][Full Text] [Related]
5. Altered in-vitro and in-vivo expression of glial glutamate transporter-1 following exposure to cerebrospinal fluid of amyotrophic lateral sclerosis patients.
Shobha K; Vijayalakshmi K; Alladi PA; Nalini A; Sathyaprabha TN; Raju TR
J Neurol Sci; 2007 Mar; 254(1-2):9-16. PubMed ID: 17254611
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of metabotropic glutamate receptor inhibition on amyotrophic lateral sclerosis-cerebrospinal fluid toxicity in vitro.
Anneser JM; Chahli C; Borasio GD
Neuroscience; 2006 Sep; 141(4):1879-86. PubMed ID: 16820266
[TBL] [Abstract][Full Text] [Related]
7. The neuroexcitotoxic amino acids glutamate and aspartate are altered in the spinal cord and brain in amyotrophic lateral sclerosis.
Plaitakis A; Constantakakis E; Smith J
Ann Neurol; 1988 Sep; 24(3):446-9. PubMed ID: 2906529
[TBL] [Abstract][Full Text] [Related]
8. Plasma glutamate and glycine levels in patients with amyotrophic lateral sclerosis.
Andreadou E; Kapaki E; Kokotis P; Paraskevas GP; Katsaros N; Libitaki G; Petropoulou O; Zis V; Sfagos C; Vassilopoulos D
In Vivo; 2008; 22(1):137-41. PubMed ID: 18396796
[TBL] [Abstract][Full Text] [Related]
9. Plasma amino acids concentration in amyotrophic lateral sclerosis patients.
Iłzecka J; Stelmasiak Z; Solski J; Wawrzycki S; Szpetnar M
Amino Acids; 2003 Jul; 25(1):69-73. PubMed ID: 12836061
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid from amyotrophic lateral sclerosis patients preferentially elevates intracellular calcium and toxicity in motor neurons via AMPA/kainate receptor.
Sen I; Nalini A; Joshi NB; Joshi PG
J Neurol Sci; 2005 Aug; 235(1-2):45-54. PubMed ID: 15936037
[TBL] [Abstract][Full Text] [Related]
11. Fasting plasma and CSF amino acid levels in amyotrophic lateral sclerosis: a subtype analysis.
Camu W; Billiard M; Baldy-Moulinier M
Acta Neurol Scand; 1993 Jul; 88(1):51-5. PubMed ID: 8372631
[TBL] [Abstract][Full Text] [Related]
12. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis.
Rothstein JD; Martin LJ; Kuncl RW
N Engl J Med; 1992 May; 326(22):1464-8. PubMed ID: 1349424
[TBL] [Abstract][Full Text] [Related]
13. Plasma glutamate and glycine levels in patients with amyotrophic lateral sclerosis: the effect of riluzole treatment.
Andreadou E; Kapaki E; Kokotis P; Paraskevas GP; Katsaros N; Libitaki G; Zis V; Sfagos C; Vassilopoulos D
Clin Neurol Neurosurg; 2008 Mar; 110(3):222-6. PubMed ID: 18055102
[TBL] [Abstract][Full Text] [Related]
14. In vitro neurotoxic properties and excitatory aminoacids concentration in the cerebrospinal fluid of amyotrophic lateral sclerosis patients. Relationship with the degree of certainty of disease diagnoses.
Fiszman ML; Ricart KC; Latini A; Rodríguez G; Sica RE
Acta Neurol Scand; 2010 Feb; 121(2):120-6. PubMed ID: 19804473
[TBL] [Abstract][Full Text] [Related]
15. Glutamate dysfunction and selective motor neuron degeneration in amyotrophic lateral sclerosis: a hypothesis.
Plaitakis A
Ann Neurol; 1990 Jul; 28(1):3-8. PubMed ID: 1973889
[TBL] [Abstract][Full Text] [Related]
16. Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis.
Rothstein JD; Tsai G; Kuncl RW; Clawson L; Cornblath DR; Drachman DB; Pestronk A; Stauch BL; Coyle JT
Ann Neurol; 1990 Jul; 28(1):18-25. PubMed ID: 2375630
[TBL] [Abstract][Full Text] [Related]
17. Decreased chloride levels of cerebrospinal fluid in patients with amyotrophic lateral sclerosis.
Watanabe S; Kimura T; Suenaga K; Wada S; Tsuda K; Kasama S; Takaoka T; Kajiyama K; Takeda M; Yoshikawa H
J Neurol Sci; 2009 Oct; 285(1-2):146-8. PubMed ID: 19595376
[TBL] [Abstract][Full Text] [Related]
18. RANTES levels are elevated in serum and cerebrospinal fluid in patients with amyotrophic lateral sclerosis.
Rentzos M; Nikolaou C; Rombos A; Boufidou F; Zoga M; Dimitrakopoulos A; Tsoutsou A; Vassilopoulos D
Amyotroph Lateral Scler; 2007 Oct; 8(5):283-7. PubMed ID: 17852013
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid erythropoietin (EPO) in amyotrophic lateral sclerosis.
Brettschneider J; Widl K; Schattauer D; Ludolph AC; Tumani H
Neurosci Lett; 2007 Apr; 416(3):257-60. PubMed ID: 17368721
[TBL] [Abstract][Full Text] [Related]
20. Decreased cerebrospinal fluid cytochrome c levels in patients with amyotrophic lateral sclerosis.
Iłzecka J
Scand J Clin Lab Invest; 2007; 67(3):264-9. PubMed ID: 17454840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
